Average Co-Inventor Count = 3.34
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rigel Pharmaceuticals, Incorporated (13 from 488 patents)
13 patents:
1. 7776847 - Benzisothiazoles useful for treating or preventing HCV infection
2. 7714137 - Pyridyl substituted heterocycles useful for treating or preventing HCV infection
3. 7569580 - Heterotricyclic compounds for use as HCV inhibitors
4. 7514434 - Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
5. 7498353 - Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
6. 7410979 - Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
7. 7358259 - HCV inhibitors and methods of using them
8. 7332602 - Pyridyl substituted heterocycles useful for treating or preventing HCV infection
9. 7157473 - Pyridyl substituted heterocycles useful for treating or preventing HCV infection
10. 7153880 - Substituted diphenyl heterocycles useful for treating HCV infection
11. 7132234 - Methods and compositions for the identification of anti-poxvirus agents
12. 6927031 - Methods for identifying polypeptide factors interacting with RNA
13. 6759538 - Substituted diphenyl heterocycles useful for treating HCV infection